Technology & Intellectual Property

Preserving existing innovation while building a broader technology platform.

GCAN's technology strategy begins with the biotechnology intellectual property, development assets, and scientific relationships established through its historical operations. The Company intends to preserve and evaluate those assets while expanding into complementary technologies, licensing opportunities, strategic partnerships, and acquisitions.

Explore the Portfolio Our Strategy
Portfolio Overview

A technology foundation with multiple potential value pathways

GCAN's existing portfolio includes biotechnology intellectual property, therapeutic development assets, and scientific relationships that remain part of the Company's long-term strategic foundation.

The Company intends to assess each asset based on scientific merit, commercial potential, strategic fit, resource requirements, and available partnership opportunities.

Depending on those factors, GCAN may pursue development, licensing, strategic collaboration, joint ventures, commercialization, or other structures designed to preserve and maximize value.

View Portfolio Pathways
GCAN technology and intellectual property portfolio
Portfolio Pathways

Flexible options for technology development and monetization

GCAN intends to evaluate multiple strategic pathways rather than relying on a single development or commercialization model.

Licensing

License technology or development rights to strategic partners with the resources, expertise, or distribution capability to advance commercialization.

Strategic Partnerships

Collaborate with scientific, operating, or commercial partners to share expertise, resources, risk, and opportunity.

Selective Development

Continue development selectively where the scientific rationale, economics, available resources, and strategic opportunity justify additional investment.

Joint Ventures

Combine GCAN assets with complementary technologies, teams, capital, or commercialization capabilities through structured joint ventures.

Commercialization

Pursue commercialization arrangements where market access, regulatory pathways, and partner capabilities support a practical route to revenue.

Technology Acquisitions

Expand the portfolio through acquisitions of complementary technologies, intellectual property, development platforms, or operating businesses.

GCAN biotechnology foundation
Biotechnology Foundation

Existing biotech assets remain part of GCAN's future

GCAN's historical biotechnology operations generated intellectual property, therapeutic development work, and scientific relationships associated with proprietary delivery technologies and cannabinoid-based research.

Those assets remain part of the Company's portfolio. GCAN intends to continue evaluating appropriate development, licensing, partnership, and commercialization strategies while balancing scientific opportunity with capital discipline.

  • Preserve and maintain existing intellectual property rights
  • Evaluate development and commercialization pathways
  • Consider licensing, partnering, and joint venture structures
  • Assess strategic fit within the Company's broader growth platform
  • Seek value-maximizing outcomes rather than abandonment of the portfolio
Review Investor Information
Expanding Technology Focus

GCAN's future technology strategy is not limited to a single product or discipline

While biotechnology remains part of the Company's foundation, GCAN intends to evaluate technologies and intellectual property beyond its historical focus.

The Company is particularly interested in opportunities where proprietary systems, specialized expertise, defensible market positions, and scalable business models can support long-term enterprise value.

Potential areas of strategic interest

  • Proprietary technology platforms
  • Specialized intellectual property portfolios
  • Technology-enabled operating businesses
  • Regulated or specialized industries
  • Commercialization and licensing platforms
  • Businesses with defensible technical or market advantages
Our Technology Principles

Innovation guided by strategy and capital discipline

GCAN intends to pursue technology opportunities with a practical focus on value, defensibility, execution, and commercial potential.

Protect What Exists

Preserve existing intellectual property and development rights where they may retain strategic or commercial value.

Partner Intelligently

Work with organizations that bring complementary scientific, operational, regulatory, financial, or distribution capabilities.

Develop Selectively

Invest additional capital only where the opportunity, evidence, economics, and strategic fit support continued development.

Expand Thoughtfully

Add technologies and businesses that strengthen the platform rather than creating disconnected or speculative growth.

Explore GCAN's broader growth platform

Learn how technology, acquisitions, partnerships, and disciplined execution fit together.

View Our Strategy